Form 8-K - Current report:
SEC Accession No. 0001437749-24-029310
Filing Date
2024-09-16
Accepted
2024-09-16 17:00:42
Documents
18
Period of Report
2024-09-16
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20240903_8k.htm   iXBRL 8-K 36563
2 EXHIBIT 99.1 ex_720840.htm EX-99.1 15874
3 EXHIBIT 99.2 ex_720841.htm EX-99.2 267360
8 ex_720840img002.jpg GRAPHIC 2831
9 opko.jpg GRAPHIC 3372
  Complete submission text file 0001437749-24-029310.txt   483364

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA opk-20240916.xsd EX-101.SCH 3401
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240916_def.xml EX-101.DEF 11421
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240916_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240916_pre.xml EX-101.PRE 11581
20 EXTRACTED XBRL INSTANCE DOCUMENT opk20240903_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 241301784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)